Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)
China flag China · Delayed Price · Currency is CNY
26.55
-0.48 (-1.78%)
Feb 11, 2026, 4:00 PM EST

SHA:688163 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
45.5544.2938.7764.276.4863.17
Depreciation & Amortization
19.9719.9717.1614.915.04-
Other Amortization
0.370.370.240.240.24-
Loss (Gain) From Sale of Assets
-1.44-1.44--0.25-
Asset Writedown & Restructuring Costs
1.031.030.02-0.951.02-
Loss (Gain) From Sale of Investments
1.011.01-10.33-16.040.79-
Provision & Write-off of Bad Debts
0.740.740.79-0.530.6-
Other Operating Activities
-0.883.214.390.190.8335.18
Change in Accounts Receivable
-10.42-10.42-22.993.2-4.48-
Change in Inventory
-1.56-1.566.13-4.33-0.48-
Change in Accounts Payable
-4.32-4.32-0.57.871-
Change in Other Net Operating Assets
----0.79-
Operating Cash Flow
47.4350.2532.8267.9192.2998.35
Operating Cash Flow Growth
-13.87%53.12%-51.67%-26.41%-6.17%20.16%
Capital Expenditures
-75.35-59.37-28.67-26.46-27.61-17.92
Sale of Property, Plant & Equipment
0.230.010.02-0.330.01
Investment in Securities
-71.9370.83-305-349.85-6515
Other Investing Activities
0.275.2717.7115.891.760.82
Investing Cash Flow
-146.7816.73-315.94-360.42-90.52-2.1
Long-Term Debt Repaid
--1.15-0.69-1.34-1.31-
Net Debt Issued (Repaid)
-1.15-1.15-0.69-1.34-1.31-
Issuance of Common Stock
---790.61--
Common Dividends Paid
-34.63-34.63-81.16-97.39--105.51
Dividends Paid
-34.63-34.63-81.16-97.39--105.51
Other Financing Activities
-0.46----2.7-3.85
Financing Cash Flow
-36.23-35.77-81.84691.87-4.01-109.35
Foreign Exchange Rate Adjustments
0.16-0.030.160.49-0.12-0.38
Net Cash Flow
-135.4231.19-364.81399.85-2.36-13.48
Free Cash Flow
-27.92-9.124.1541.4664.6880.43
Free Cash Flow Growth
---90.00%-35.91%-19.58%41.77%
Free Cash Flow Margin
-14.19%-4.68%2.18%23.79%30.99%43.34%
Free Cash Flow Per Share
-0.26-0.080.040.410.800.99
Cash Income Tax Paid
18.9713.3325.0212.8616.8518.29
Levered Free Cash Flow
-30.69-23.72-3.932.1634.4843.23
Unlevered Free Cash Flow
-30.56-23.45-3.532.5834.9343.23
Change in Working Capital
-18.93-18.93-18.225.9-2.96-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.